Treatment types for inhibitors

When the immune system blocks factor replacement, treatment plans change — this page explains options in plain language for Nepal.

What an inhibitor is

An inhibitor is an antibody that stops infused factor VIII or IX from working properly. It can appear after many infusions or, in some children, in the first months after diagnosis.

Standard factor doses may no longer stop bleeds. Bleeds can become harder to treat and more expensive everywhere in the world, including Nepal.

Bypassing agents and high-dose factor

Treatment centres may use bypassing agents such as activated prothrombin complex concentrate or recombinant factor VIIa for bleeding when inhibitors are present. Availability in Nepal varies by hospital and humanitarian shipments.

High-dose factor regimens or immune tolerance induction are specialist plans requiring sustained product supply and monitoring — not decisions made at home.

Emicizumab and non-factor paths

Emicizumab helps some people with haemophilia A, including some with inhibitors. It is not factor VIII and must not be confused with it. Haemophilia B with inhibitors carries different risks; products are not interchangeable.

Only your centre can say whether a named non-factor medicine is on shelf for you this month.

Records and emergency rules

Carry a card stating inhibitor status, last treatment, and centre phone number. Head injury rules become stricter, not relaxed.

Every infusion or injection should be logged with product name and batch. NHS advocates for inhibitor testing when bleeds stop responding to usual doses.

This page is general information from Nepal Hemophilia Society. It is not a diagnosis or a treatment plan. A bleed, a head injury, or bleeding after an accident needs urgent hospital care. Ask your treatment centre before you change any treatment.